Investor Eye: SVB Speaks On Investment Slowdown, Securing An Exit, But Also Optimism

In a panel discussion at the TCT conference in Boston and in a recently published report, Jonathan Norris of Silicon Valley Bank explained why health care investment has slowed this year, and why remaining pragmatic and optimistic is important moving forward.

Investor Eye Fetaure Image

Investment in the life sciences has been very different in 2022 compared to 2021.

Deal volume and value is down, leading some investors and key opinion leaders to say that the market is struggling.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business